Mycronic receives order for a Prexision-8 mask writer

Täby, 30 December, 2015 - Mycronic AB (publ), has received an order for a mask writer from the Prexision series for display applications from a customer in Asia. The system is scheduled to be delivered during the fourth quarter of 2016.

Mycronic offers mask writers for the manufacturing of photomasks within different fields of application. These areas are display manufacturing (for TV, smart phones and tablets among other things) and applications within the multi-purpose market, a broad segment comprising many different application areas.

”The customer has placed an order for a Prexsion-8 mask writer. The system includes adaptations, which makes an upgrade possible, to a full scale Generation 10 photomask production unit,” says Magnus Råberg, Senior VP & General Manager for business area PG at Mycronic AB. With this order Mycronic has filled up the possibilities to deliver advanced mask writers for display applications during 2016,” Magnus Råberg concludes.

The price level for a Prexision-8 mask writer is normally in the span USD 25-30 million depending on configuration and customization.

Contacts at Mycronic:

Magnus Råberg                                                               
Sr VP & General Manager PG                                           
Tel: +46 8 638 52 00                                                       
magnus.raberg@mycronic.com                                        

Per Ekstedt
CFO
Tel: +46 8 638 52 00
per.ekstedt@mycronic.com

About Mycronic AB
Mycronic AB is a Swedish high-tech company engaged in the developing, manufacturing and marketing of production equipment for the electronics industry. Mycronic headquarters are located in Täby, north of Stockholm and the Group has subsidiaries in China, France, Germany, Japan, Singapore, South Korea, the Netherlands, United Kingdom and the United States. For more information see our web site at: www.mycronic.com 

Mycronic AB (publ) is listed on NASDAQ Stockholm, Mid Cap: MYCR.

The information is of the type that Mycronic is required to disclose under the Financial Instruments trading Act and/or the Swedish Securities Markets Act. The information was submitted for publication on 30 December, 2015.